Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans

Eur J Pharm Sci. 2013 Aug 16;49(5):850-7. doi: 10.1016/j.ejps.2013.06.007. Epub 2013 Jun 19.

Abstract

Amphotericin B (AmB) is a polyene antibiotic produced by Streptomyces nodosus used for more than 50 years in the treatment of acute systemic fungal infections. It exhibits a broad spectrum of activity against fungal and protozoan pathogens with relatively rare resistance. The aim of this study was to prepare and evaluate the utility of the AmB-Cu(2+) complex as a potential compound with a high fungicidal activity at lower concentrations, compared with conventional AmB. It was hypothesized that insertion of copper ions into fungal cell membranes, together with the AmB-Cu(2+) complex bypassing the natural homeostatic mechanisms of this element, may contribute to the increased fungicidal activity of AmB. The analysis of results indicates the increased antifungal activity of the AmB-Cu(2+) complex against Candida albicans in comparison with the pure AmB and Fungizone. Additionally, it was stated that the increased antifungal activity of the AmB-Cu(2+) complex is not the sum of the toxic effects of AmB and Cu(2+) ions, but is a result of the unique structure of this compound.

Keywords: Amphotericin B; Amphotericin B copper(II) complex; Antifungal activity; Candida albicans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage*
  • Amphotericin B / chemistry
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / chemistry
  • Candida albicans / drug effects*
  • Copper / administration & dosage*
  • Copper / chemistry
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Copper
  • Amphotericin B